Esperoct (Antihemophilic factor (recombinant), glycopegylated-exei PFS) 500IU

Esperoct 500 IU is a glycopegylated recombinant antihemophilic factor used to manage hemophilia A. This pre-filled syringe formulation provides a convenient option for factor replacement therapy. Store between 2-8°C to maintain potency. Always follow healthcare provider guidance for use.

Strength

500IU

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Novo Nordisk Pharma Switzerland

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Esperoct 500 IU is used to prevent and control bleeding episodes in patients with hemophilia A. It works by temporarily replacing the missing clotting factor VIII that the body needs to form blood clots. This medication is prescribed for routine prophylaxis as well as on-demand treatment of bleeds. It helps maintain adequate factor levels to support normal blood clotting processes.

Side Effects

Esperoct 500 IU helps restore normal clotting function during bleeding episodes or for routine prevention. Users may experience reduced frequency of bleeding when used as directed. The medication works gradually to support the body's natural clotting ability. Most effects are observed as improved bleeding control rather than immediate sensations.

Precautions & Warnings

Keep Esperoct 500 IU refrigerated between 2-8°C and protect from light. Do not freeze. Always check the expiration date before use. Use only if the solution is clear and colorless. Dispose of used syringes in a proper sharps container. Follow your healthcare provider's instructions for proper handling and storage.

Avoid Interactions

No specific drug interactions are widely documented with Esperoct 500 IU. However, other medications that affect blood clotting may alter its effectiveness. Always inform your healthcare provider about all medications you are taking. Avoid mixing with other solutions in the same syringe. Follow medical advice regarding concurrent use of pain relievers or other therapies.

Frequently Asked Questions

Esperoct 500 IU is used to prevent and treat bleeding in patients with hemophilia A by replacing missing clotting factor VIII.

Store between 2-8°C and protect from light; do not freeze. Check expiration before use.

Use only as directed by your healthcare provider. Proper training is required before self-administration.

Inspect the solution for clarity and color. Ensure it is within the expiration date and stored correctly.

No widely documented interactions exist, but inform your doctor about all medications you are taking.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.